Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Guillain-Barré syndrome in Denmark: a population-based study on epidemiology, diagnosis and clinical severity

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Characteristic muscle signatures assessed by quantitative MRI in patients with Bethlem myopathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Physical activity in myotonic dystrophy type 1

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. High-intensity training in patients with spinal and bulbar muscular atrophy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Lithium-Induced Downbeat Nystagmus and Horizontal Gaze Palsy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Simultan bilateral perifer facialisparese er en sjælden præsentationsform af Guillain-Barrés syndrom

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Cerebral sinustrombose ved Behçets sygdom

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

Vis graf over relationer

OBJECTIVES: To describe the epidemiology and clinical heterogeneity of Guillain-Barré syndrome (GBS) in Denmark and to compare a population-based cohort to prospectively included patients in the International GBS Outcome Study (IGOS).

METHODS: The incidence rate (IR) of GBS in Denmark from September 2012 to December 2015, applying the National Institute of Neurological Disorders and Stroke (NINDS) diagnostic criteria, was estimated and the level of diagnostic certainty was described with the Brighton criteria. All cases registered with a diagnosis of GBS or other inflammatory neuropathies in the Danish National Hospital Registry were reviewed for diagnostic criteria and for information on treatment and clinical course.

RESULTS: A total of 299 GBS cases were confirmed, corresponding to a crude IR of 1.59 (95% CI 1.42-1.78) per 100,000 per year. The Brighton criteria level 1-3 of diagnostic certainty was met in 279 (93%) of the patients. Thirty-five percent of the patients were mildly affected (GBS disability score < 3) and a correlation between high age and high disability score at nadir was found (Spearman's rank correlation coefficient 0.42, p < 0.0001). The group of 89 (30%) patients who were enrolled in IGOS had higher GBS disability score at nadir, were admitted 5 days earlier, reached nadir 4 days faster, and a larger proportion received treatment with IVIg (all p < 0.05).

CONCLUSION: The epidemiology and full clinical spectrum of GBS are described in a population-based study. This includes a larger proportion of milder cases that are underrepresented in prospective cohorts such as IGOS.

OriginalsprogEngelsk
TidsskriftJournal of Neurology
Vol/bind266
Udgave nummer2
Sider (fra-til)440-449
Antal sider10
ISSN0340-5354
DOI
StatusUdgivet - 2019

ID: 56482199